Real-time enrollment status for this sle (systemic lupus) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT06925542 |
| Recruiting Status | Recruiting |
| Condition | SLE (Systemic Lupus) |
| Phase | PHASE1 |
| Target Enrollment | 80 participants |
| Active Locations | 9 sites in the US |
| Sponsor | CRISPR Therapeutics |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 12, 2026: Clinical trial NCT06925542 is currently recruiting participants. This phase1 study for sle (systemic lupus) is actively seeking new participants at 9 locations across the United States. The study is sponsored by CRISPR Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06925542 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06925542 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.